Sign inJoin waitlistJoin the waitlist

YW

Yu-Ning Wong

Program Director, GU Medical Oncology Services, Fox Chase Cancer Center · University of Pennsylvania Health System

Credentials: · · · ·

History

Temple University Hospital
2002–2004
Internal Medicine
Thomas Jefferson University Hospital
1999–2002
Robert Wood Johnson Medical School
1995–1999

Research

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
New England Journal of Medicine · 2015 · 2,355 citations
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work
Medical Care · 2015 · 617 citations
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network
Cancer · 2012 · 533 citations

Robert Uzzo
27 papers
Elizabeth Plimack
18 papers
Alexander Kutikov
17 papers
RT
Richard Theriault
16 papers
Stephen Edge
16 papers
JW
Jane Weeks
14 papers
Joaquim Bellmunt
13 papers
Marc Smaldone
12 papers · 12 as a resident
Matthew Galsky
12 papers
Daniel Geynisman
11 papers
Katrina Armstrong
11 papers
JR
Jonathan Rosenberg
10 papers

Grants

Clinical and Social Implications of Cost Sharing for Cancer Drugs
National Cancer Institute · K07
Contact PI · $826.5K · Fox Chase Cancer Center
2008–2013

Clinical trials

Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer
Principal investigator · Withdrawn · Phase 2
Fox Chase Cancer Center
2008
Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer
Principal investigator · Completed · Phase 2
Fox Chase Cancer Center
2006–2012
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Site PI · Recruiting · Phase 3
Canadian Cancer Trials Group
2025–2031
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Site PI · Recruiting
Alliance for Clinical Trials in Oncology
2020–2026